28.10.2013
- Potential For Success - There is great promise for innovative R&D, generics and active pharmaceutical ingredient (API) manufacture in Russia and the countries that make up Central...
09.09.2013
- New Focus - The importance of Indian companies in the global pharmaceutical supply chain is well known and well documented. Large quantities of base chemicals, intermediates...
06.08.2013
- One-Time Fee - On Oct. 1, 2012, the U. S. Food and Drug Administration (FDA) implemented the long-discussed Generic Drug User Fee Act (GDUFA) , thereby authorizing the agency to...
06.08.2013
- Adaptation and Growth - For years, pharmaceutical companies have turned to emerging markets as low cost manufacturing destinations, utilizing lower wages and, frequently, less...
20.11.2012
- New Markets - An estimated 25 million people in the U.S. suffer from rare diseases, known in the pharmaceutical industry as "orphan diseases". While the prevalence of each...
17.04.2012
- In recent years many companies have touted their expansion into emerging markets as a means of lowering costs, increasing sales and expanding their global presence. Much of the...
13.01.2012
- The pharmaceutical supply chain is increasingly globalized. It is estimated that 80% of the active ingredients used in generic medicines marketed in the U.S. are manufactured in...
19.10.2011
- Paradigm Shift - The number of API manufacturers in India and China focused on supplying active ingredients to regulated markets has grown considerably over the past few years...
